A Phase 4, Randomized, Double-blind, Placebo-controlled, Multicenter, Parallel-group Study of the Effect of Dupilumab on Sleep Disturbance in Patients With Uncontrolled Persistent Asthma
Public ClinicalTrials.gov record NCT04502862. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Primary Objective: To assess the effect of dupilumab on sleep Secondary Objectives: * To evaluate the effect of dupilumab on additional participant reported sleep outcomes * To evaluate the effect of dupilumab on objective sleep assessment * To evaluate the effect of dupilumab on asthma symptoms * To evaluate the effect of dupilumab on lung function * To evaluate the safety of dupilumab
Study identification
- NCT ID
- NCT04502862
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 202 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 9, 2020
- Primary completion
- Oct 2, 2023
- Completion
- Nov 9, 2023
- Last update posted
- Dec 5, 2024
2020 – 2023
United States locations
- U.S. sites
- 12
- U.S. states
- 9
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Kern Allergy and Medical Research. Inc. Site Number : 8400003 | Bakersfield | California | 93301 | — |
| Todd Astor MD Site Number : 8400016 | Culver City | California | 90230 | — |
| Southern California Institute for Respiratory Diseases Site Number : 8400009 | Los Angeles | California | 90048 | — |
| Allergy & Asthma Associates of Santa Clara Valley Site Number : 8400001 | San Jose | California | 95117 | — |
| Asthma and Allergy Associates, PC Site Number : 8400011 | Colorado Springs | Colorado | 80907 | — |
| Sarasota Clinical Research Site Number : 8400012 | Sarasota | Florida | 34239 | — |
| Allergy & Asthma Specialists, PSC Site Number : 8400004 | Owensboro | Kentucky | 42301 | — |
| The Asthma and Allergy Center Site Number : 8400010 | Bellevue | Nebraska | 68123 | — |
| OK Clinical Research LLC Site Number : 8400005 | Edmond | Oklahoma | 73034 | — |
| Velocity Clinical Research, Medford Site Number : 8400007 | Medford | Oregon | 97504 | — |
| National Allergy and Asthma Research, LLC Site Number : 8400008 | Charleston | South Carolina | 29407 | — |
| TTS Research Site Number : 8400006 | Boerne | Texas | 78006 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 43 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04502862, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 5, 2024 · Synced Sep 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04502862 live on ClinicalTrials.gov.